| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |